Ecstasy induced acute hepatic failure. Case reports
ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.78, sa.1, ss.53-55, 2015 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 78 Sayı: 1
- Basım Tarihi: 2015
- Dergi Adı: ACTA GASTRO-ENTEROLOGICA BELGICA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
- Sayfa Sayıları: ss.53-55
- Anahtar Kelimeler: acute hepatic failure, exctasy, LIVER-TRANSPLANTATION, MDMA, HEPATOTOXICITY, INGESTION, 3,4-METHYLENEDIOXYAMPHETAMINE, MECHANISMS, DEATHS, CYP2D6, DRUGS, RAT
- İnönü Üniversitesi Adresli: Evet
Özet
3,4-methylenedioxymethamphetamine (MDMA), an amphetamine derivative known as ecstasy, has stimulating and hallucinogenic properties. It has become a substance that is widely used especially by young people. Hepatotoxicity is one of the rare side effects of this substance and can be fatal. Ecstasy-induced fulminant hepatitis has been reported in case reports. The clinical course and the prognosis of the cases may differ. In this article, two cases in whom ecstasy-induced fulminant hepatic failure had developed and who were treated with liver transplantation, and one case which recovered with treatment, have been presented.